Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-22FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for amlodipine besylate and benazepril hydrochloride from Dr. Reddy's Laboratories Limited, authoriz…
-
FDA approval · 2019-11-22FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for amlodipine besylate and benazepril hydrochloride, authorizing a fixed-dose combination product f…
-
FDA approval · 2019-11-21FDA Approved: ATENOLOL — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved atenolol as a generic drug under an Original Application (ANDA) from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2019-11-18FDA Approved: AMLODIPINE AND ATORVASTATIN — Original Application (Apotex Corp.)
FDA approved the original application for a generic fixed-dose combination of amlodipine and atorvastatin, manufactured by Apotex Corp., for…
-
FDA approval · 2019-11-14FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for spironolactone from Mylan Pharmaceuticals Inc., enabling continued marketing of the product and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-11-14FDA Approved: SPIRONOLACTONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA has approved a supplemental application for spironolactone from Jubilant Cadista Pharmaceuticals Inc. under the ANDA framework.
-
FDA approval · 2019-11-07FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) through Organon LLC.
-
FDA approval · 2019-11-06FDA Approved: QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for quinapril and hydrochlorothiazide fixed-dose combinations in three dosage strengths (10/12.5, 20…
-
FDA approval · 2019-11-06FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for IRBESARTAN from Camber Pharmaceuticals, Inc., approving changes related to this product's use or…
-
FDA approval · 2019-11-06FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved Alembic Pharmaceuticals' supplemental application for a Telmisartan and Hydrochlorothiazide generic product.
-
FDA approval · 2019-11-06FDA Approved: QUINAPRIL HCL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Quinapril HCl and Hydrochlorothiazide, a fixed-dose combination product. Th…
-
FDA approval · 2019-11-06FDA Approved: VALSARTAN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for valsartan from Ascend Laboratories, updating the regulatory status of this generic antihypertens…
-
FDA approval · 2019-11-06FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application to allow Mylan Pharmaceuticals to market a generic spironolactone and hydrochlorothiazide combinatio…
-
FDA approval · 2019-11-04FDA Approved: TELMISARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved a supplemental application for Telmisartan submitted by Jubilant Cadista Pharmaceuticals Inc., under the ANDA pathway. The …
-
FDA approval · 2019-11-04FDA Approved: TELMISARTAN — Supplemental Application (Micro Labs Limited)
The FDA approved a supplemental application for Telmisartan submitted by Micro Labs Limited.
-
FDA approval · 2019-11-01FDA Approved: QUINAPRIL — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for quinapril filed by Solco Healthcare US, LLC under ANDA205823.
-
FDA approval · 2019-11-01FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of spironolactone and hydrochlorothiazide from Sun Pharmace…
-
FDA approval · 2019-10-30FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate by Hospira, Inc. under ANDA 078085, finalizing changes to the generic produc…
-
FDA approval · 2019-10-24FDA Approved: METOPROLOL — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved Baxter Healthcare Corporation's supplemental application for Metoprolol Tartrate under ANDA 078950. This approval updates a…
-
FDA approval · 2019-10-24FDA Approved: AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s supplemental application for a combination tablet of amlodipine besylate and olmesartan medoxomil …
-
FDA approval · 2019-10-24FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the generic combination drug Amlodipine and Olmesartan Medoxomil, manufactured by Macleods Pharm…
-
FDA approval · 2019-10-17FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approves a supplemental application for Benicar (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2019-10-01FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
The FDA approved a supplemental application for Verapamil Hydrochloride by Teva Pharmaceuticals Inc., updating the drug’s labeling and appro…
-
FDA approval · 2019-09-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Verapamil Hydrochloride from Glenmark Pharmaceuticals, updating an already approved generic …
-
FDA approval · 2019-09-26FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for lisinopril filed by Solco Healthcare U.S., LLC under an ANDA. The action authorizes changes …